sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 651-675 out of 1314.

<< < 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 > >>

Public Release: 4-Nov-2015
PLOS Medicine
Relapsing infections could challenge malaria eradication
Eliminating malaria in the Asia-Pacific could prove more challenging than previously thought, with new research showing that most childhood malaria infections in endemic areas are the result of relapsed, not new, infections.
TransEPI Consortium, Bill & Melinda Gates Foundation, National Health and Medical Research Council, Swiss National Science Foundation, Cellex Foundation, and others

Contact: Liz Williams
Walter and Eliza Hall Institute

Public Release: 3-Nov-2015
Professor receives grant to seek a cure for a leading cause of death in children under 5
Lesly Temesvari, an Alumni Distinguished Professor and Fulbright Scholar in Clemson University's biological sciences department, has been awarded a two-year, $290,400 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Lesly Temesvari
Clemson University

Public Release: 3-Nov-2015
Proceedings of the National Academy of Sciences
Link between small mammals and evolution of hepatitis A virus to humans discovered
Researchers at the University of North Carolina at Chapel Hill are part of an international team led by the University of Bonn, Germany, who have found a link between the origin of hepatitis A virus (HAV) and small mammals. With the emergence of Ebola virus from bats and hantaviruses from rodents, investigators say identifying the other species infected with HAV provides novel insight into the evolution of HAV and how it spread to humans.
National Institutes of Health

Contact: Morag MacLachlan
University of North Carolina at Chapel Hill

Public Release: 3-Nov-2015
Proceedings of the National Academy of Sciences
The hepatitis A virus is of animal origin
The hepatitis A virus can trigger acute liver inflammation which generally has a mild course in small children but which can become dangerous in adults. The virus has previously been considered to be a purely human pathogen. An international team of researchers under the direction of the University of Bonn has now discovered that the hepatitis A virus is of likely animal origin. The results currently appear in the renowned journal PNAS.

Contact: Prof. Dr. Jan Felix Drexler
University of Bonn

Public Release: 3-Nov-2015
Early hospitalization key to survival for Ebola victims
Scientists looked at data from nearly 1,000 cases over 38 years in the Democratic Republic of Congo, which has experienced more Ebola outbreaks than any other country since the virus was discovered in 1976.

Contact: Zoe Dunford

Public Release: 3-Nov-2015
Vast energy value in human waste: UN University
UN University's Canadian-based water institute estimates that biogas potentially available from human waste worldwide would have a value of up to US$ 9.5 billion in natural gas equivalent. And the residue, dried and charred, could produce 2 million tonnes of charcoal-equivalent fuel, curbing the destruction of trees. The large energy value would prove small, however, relative to that of the global health and environmental benefits that would accrue from the safe treatment of human waste in low-resource settings.

Contact: Terry Collins
United Nations University

Public Release: 2-Nov-2015
US and Mexico must jointly combat Chagas disease
Chagas disease -- the third most common parasitic infection in the world -- affects approximately 7.5 million people, mostly in Latin America. To help reduce outbreaks of this disease in their countries, the United States and Mexican governments should implement a range of programs as well as fund research for the development of Chagas vaccines and treatments, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

Contact: Jeff Falk
Rice University

Public Release: 2-Nov-2015
BIDMC researchers win 2015 Dvorak Young Investigator Award
Beth Israel Deaconess Medical Center scientists Anders Berg, M.D., Ph.D., and David Friedman, M.D., whose research is exploring genetic changes underlying kidney disease, have been awarded the 2015 Dvorak Young Investigator Award.

Contact: Bonnie Prescott
Beth Israel Deaconess Medical Center

Public Release: 2-Nov-2015
Canadian Medical Association Journal
Substantial differences in obstetric care for First Nations women in Canada: BC study
There are substantial differences in obstetric care provided to First Nations women compared with women in the general population, and these differences may contribute to higher infant mortality in First Nations populations, according to research published in Canadian Medical Association Journal.

Contact: Kim Barnhardt
Canadian Medical Association Journal

Public Release: 1-Nov-2015
Expert Review of Vaccines
Could self-disseminating vaccines cut off emerging infectious diseases at source?
An expert review identifies state-of-the-art of self-disseminating vaccines as a new and potentially powerful strategy to circumvent diseases such as Ebola at the animal source before their establishment as the next human pandemic

Contact: Andrew Gould
University of Plymouth

Public Release: 29-Oct-2015
PLOS Neglected Tropical Diseases
UTMB researchers help discover simple, affordable diagnostic kit for chikungunya
A novel and affordable diagnostic test for chikungunya will soon be available thanks to the work of researchers at the University of Texas Medical Branch at Galveston in partnership with a commercial lab.

Contact: Christopher Smith Gonzalez
University of Texas Medical Branch at Galveston

Public Release: 29-Oct-2015
HIV/AIDS deaths are down in South Africa -- But most are still unacknowledged
After peaking in 2007, AIDS mortality in South Africa has decreased with the widespread introduction of effective antiretroviral therapy, according to updated estimates published in AIDS, official journal of the International AIDS Society. AIDS is published by Wolters Kluwer.

Contact: Connie Hughes
Wolters Kluwer Health

Public Release: 28-Oct-2015
Journal of Insect Science
Researchers compare 'natural' mosquito repellents to DEET
Researchers at New Mexico State University tested 10 commercially available products for their effectiveness at repelling mosquitoes. The results were published in the Journal of Insect Science.

Contact: Richard Levine
Entomological Society of America

Public Release: 27-Oct-2015
Lancet Infectious Diseases
RI Hospital researcher confirms praziquantel safe after first trimester
Rhode Island Hospital researchers confirmed that praziquantel to treat schistosomiasis is safe to give pregnant women after the first trimester. The finding could prove critical to the care of pregnant and lactating women with schistosomiasis who are denied praziquantel. The study was published in The Lancet Infectious Diseases.
National Institutes of Health, NIH/National Institute of Allergy and Infectious Diseases

Contact: Beth Bailey

Public Release: 27-Oct-2015
Thousands die from snakebite each year as anti-venom treatment out of reach
Snakebite claims thousands of lives in the world's poorest communities every year but remains a 'forgotten killer,' according to a new editorial published in the British Medical Journal.

Contact: Jane Gardner
University of Melbourne

Public Release: 27-Oct-2015
ASTMH 64th Annual Meeting
New studies show nobel prize-winning drug that knocks out parasitic worms could have second act fighting malaria
A workhorse of a drug that a few weeks ago earned its developers a Nobel prize for its success in treating multiple tropical diseases is showing early promise as a novel and desperately needed tool for interrupting malaria transmission, according to new findings presented today at the American Society of Tropical Medicine and Hygiene Annual Meeting.

Contact: Preeti Singh

Public Release: 26-Oct-2015
ASTMH 64th Annual Meeting
American Journal of Tropical Medicine and Hygiene
New study unravels mystery of why deadly tick disease appears to be surging, yet fatalities have not
A mild disease spread by the aggressive Lone star tick that is now colonizing large swaths of the United States is being mistaken for Rocky Mountain spotted fever, according to a new study from scientists at the US Centers for Disease Control and Prevention. The findings may indicate a key reason reports of infections with the potentially fatal pathogen appear to be surging but deaths are not, according to researchers.

Contact: Bridget DeSimone

Public Release: 26-Oct-2015
Journal of Medical Entomology
Male mosquitoes lured to traps by sounds of female wing-beats
Male mosquitoes have been found to zero in on inexpensive traps that broadcast sound that is similar in frequency to the sound that is produced by the wing-beats of female mosquitoes -- a discovery that may lead to better mosquito control in developing countries.
National Health and Medical Research Council

Contact: Richard Levine
Entomological Society of America

Public Release: 26-Oct-2015
The Lancet
Stopping tuberculosis requires new strategy
Unless there is a major shift in the way the world fights tuberculosis -- from a reliance on biomedical solutions to an approach that combines biomedical interventions with social actions -- the epidemic and drug resistance will worsen, say researchers at Harvard T.H. Chan School of Public Health.
Wellcome Trust, National Institutes of Health

Contact: Todd Datz
Harvard T.H. Chan School of Public Health

Public Release: 22-Oct-2015
Cell Reports
How parasites take a bigger bite
A team of international scientists led by the Research Institute of the McGill University Health Centre uncovered an important mechanism behind Leishmania, a deadly parasitic disease transmitted by sandflies. In a new study published today in Cell Reports, researchers described how key molecules known as exosomes, boost the process by which the Leishmania parasite infects humans and other mammals. These findings could lead to the development of new potential vaccine targets and diagnostic tools.
Canadian Institutes of Health Research

Contact: Julie Robert
514-934-1934 x71381
McGill University Health Centre

Public Release: 22-Oct-2015
New England Journal of Medicine
NIH-funded study reveals why malaria vaccine only partially protected children, infants
Using new, highly sensitive genomic sequencing technology, an international team of researchers has found new biological evidence to help explain why the malaria vaccine candidate RTS,S/AS01 (called RTS,S) provided only moderate protection among vaccinated children during clinical testing. The researchers, funded in part by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, found that genetic variability in the surface protein targeted by the RTS,S vaccine likely played a significant role.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Emily Mullin
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 22-Oct-2015
Journal of Virological Methods
Bio-Rad's Droplet Digital™ PCR (ddPCR™) proves highly reproducible at identifying viral RNA mutations in clinical samples
Researchers show that droplet digital PCR is more sensitive, precise and reproducible at measuring viral RNA mutation rates in clinical samples than real-time PCR.

Contact: Ken Li
Chempetitive Group

Public Release: 22-Oct-2015
PLOS Pathogens
Interrupting the transmission cycle: A protein required for dengue virus infection of mosquitoes
An estimated 2 billion people are at risk for being bitten by Aedes mosquitoes and infected with the dengue virus (DENV). A study published on Oct. 22 in PLOS Pathogens introduces a candidate target for a transmission-blocking vaccine that interferes with virus infection of the mosquito after it feeds on the blood of infected hosts (such a vaccine would be a valuable complement to traditional DENV vaccines in development that seek to prevent human infection).

Contact: Tonya Colpitts

Public Release: 21-Oct-2015
American Society of Tropical Medicine & Hygiene
New England Journal of Medicine
Genomic study sheds light on protective effects of malaria vaccine candidate
An international team of researchers has used cutting edge genomic methods to uncover key biological insights that help explain the protective effects of the world's most advanced malaria vaccine candidate, RTS,S/AS01 (RTS,S). Applying highly sensitive sequencing technology to more patient samples than previously tested, the team was able to determine that genetic variation in the protein targeted by RTS,S influences the vaccine's ability to ward off malaria in young children.
NIh/National Institute of Allergy and Infectious Diseases, Bill & Melinda Gates Foundation, PATH Malaria Vaccine Initiative

Contact: Paul Goldsmith
Broad Institute of MIT and Harvard

Public Release: 21-Oct-2015
Parasites & Vectors
Leprosy and elephantiasis: New cases could be prevented in 10 years
The life chances of over one billion people could be improved through examining the transmission of nine neglected tropical diseases (NTDs), an international consortium of researchers has argued. Leprosy, Elephantiasis and Sleeping Sickness are among nine tropical diseases targeted. Neglected tropical diseases affect over one billion people worldwide.
Bill and Melinda Gates Foundation, The Novartis Foundation

Contact: Tom Frew
University of Warwick

Showing releases 651-675 out of 1314.

<< < 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 > >>